NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/25/2024
Back to search
Official data from USPTO
DRUGDEV
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
04/25/2024
Trademark type
Word
Nice classes
35
Filing date
02/07/2012
Registration date
01/14/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/25/2024
Last transaction
04/25/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
First use anywhere
01/01/2009
First use in commerce
01/01/2009
Drawing code
4
Owner type
03
Owner location
Wayne, PA
Examiner
KIDWELL WALKER, JACLYN NOEMI
Law office
M30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
DrugDev, Inc.
DrugDev, Inc.
Representatives
Cynthia Johnson Walden Fish & Richardson P.C.
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Online business networking services for clinical research professionals involved in the clinical study of medical products including pharmaceuticalsbiologicsmedical devices; management and compilation of computerized databases of clinical research professionals to provide ability to contact clinical research professionals electronically including by email to evaluate clinical study protocolstake part in clinical studies and recruit patients to take part in clinical studies
Publications
History of USPTO decisions and trademark events.
40 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/25/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/25/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/25/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
12/27/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/14/2023
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
02/19/2020
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
02/19/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/19/2020
ES8R
TEAS SECTION 8 RECEIVED
01/08/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/14/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/24/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/24/2017
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/14/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/06/2013
ALIE
ASSIGNED TO LIE
12/02/2013
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
11/07/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/07/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/06/2013
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/06/2013
DOCK
ASSIGNED TO EXAMINER
10/23/2013
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/22/2013
GNFR
FINAL REFUSAL E-MAILED
05/22/2013
CNFR
FINAL REFUSAL WRITTEN
05/22/2013
ATRV
ATTORNEY REVIEW COMPLETED
05/22/2013
NREV
NOTICE OF REVIVAL - E-MAILED
02/13/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/13/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/12/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/12/2013
PETG
PETITION TO REVIVE-GRANTED
02/12/2013
PROA
TEAS PETITION TO REVIVE RECEIVED
02/12/2013
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
12/12/2012
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
12/12/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/16/2012
GNRT
NON-FINAL ACTION E-MAILED
05/16/2012
CNRT
NON-FINAL ACTION WRITTEN
05/16/2012
DOCK
ASSIGNED TO EXAMINER
05/16/2012
MPMK
NOTICE OF PSEUDO MARK MAILED
02/14/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/13/2012
NWAP
NEW APPLICATION ENTERED
02/10/2012
Continuous trademark protection
Get notified about every new filing that threatens DRUGDEV or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.